Ferritin H is a novel marker of early erythroid precursors and macrophages

Histopathology

Volumn 62, Issue 6, 2013, Pages 931-940

  Wang, Wei ^a   Grier, David D ^a   Woo, Jennifer ^a   Ward, Martha ^a   Sui, Guangchao ^a   Torti, Suzy V ^b   Torti, Frank M ^b   Beaty, Michael W ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Erythroid precursors; Ferritin; Iron; Macrophages

Indexed keywords

FERRITIN ANTIBODY; FERRITIN H ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; BONE MARROW CELL; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC TISSUE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LIVER; LUNG ALVEOLUS MACROPHAGE; LYMPH NODE; LYMPHOCYTE; LYMPHOID CELL; LYMPHOMA; MACROPHAGE; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ANTIBODIES, MONOCLONAL; APOFERRITINS; BIOLOGICAL MARKERS; BONE MARROW CELLS; ERYTHROID PRECURSOR CELLS; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; IRON; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYMPHOMA; MACROPHAGES; MODELS, BIOLOGICAL; TUMOR MARKERS, BIOLOGICAL;

CUCURBITA;

EID: 84876813362     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12101     Document Type: Article

References (23)

1. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004; 117; 285-297.
2. Koury MJ, Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu. Rev. Nutr. 2004; 24; 105-131.
3. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002; 99; 3505-3516.
4. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008; 112; 470-478.
5. Vaisman B, Meyron-Holtz EG, Fibach E, Krichevsky AM, Konijn AM. Ferritin expression in maturing normal human erythroid precursors. Br. J. Haematol. 2000; 110; 394-401.
6. Invernizzi R, Cazzola M, De Fazio P, Rosti V, Ruggeri G, Arosio P. Immunocytochemical detection of ferritin in human bone marrow and peripheral blood cells using monoclonal antibodies specific for the H and L subunit. Br. J. Haematol. 1990; 76; 427-432.
7. Ali FM, May A, Jones BM, Jacobs A. Enrichment of erythroblasts from human bone marrow using complement-mediated lysis: measurement of ferritin. Br. J. Haematol. 1983; 53; 227-235.
8. Hodgetts J, Peters SW, Hoy TG, Jacobs A. The ferritin content of normoblasts and megaloblasts from human bone marrow. Clin. Sci. (Lond.) 1986; 70; 47-51.
9. Nakahata T, Okumura N. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leuk. Lymphoma 1994; 13; 401-409.
10. Rogers CE, Bradley MS, Palsson BO, Koller MR. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid. Exp. Hematol. 1996; 24; 597-604.
11. Scicchitano MS, McFarland DC, Tierney LA, Narayanan PK, Schwartz LW. In vitro expansion of human cord blood CD36+ erythroid progenitors: temporal changes in gene and protein expression. Exp. Hematol. 2003; 31; 760-769.
12. Dong HY, Wilkes S, Yang H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. Am. J. Surg. Pathol. 2011; 35; 723-732.
13. Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am. J. Clin. Pathol. 2010; 134; 429-435.
14. Dei Tos AP, Doglioni C, Laurino L, Fletcher CD. KP1 (CD68) expression in benign neural tumours. Further evidence of its low specificity as a histiocytic/myeloid marker. Histopathology 1993; 23; 185-187.
15. Gottfried E, Kunz-Schughart LA, Weber A et al. Expression of CD68 in non-myeloid cell types. Scand. J. Immunol. 2008; 67; 453-463.
16. Saito N, Pulford KA, Breton-Gorius J, Masse JM, Mason DY, Cramer EM. Ultrastructural localization of the CD68 macrophage-associated antigen in human blood neutrophils and monocytes. Am. J. Pathol. 1991; 139; 1053-1059.
17. Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am. J. Surg. Pathol. 2005; 29; 617-624.
18. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am. J. Clin. Pathol. 2004; 122; 794-801.
19. Gaetano C, Massimo L, Alberto M. Control of iron homeostasis as a key component of macrophage polarization. Haematologica 2010; 95; 1801-1803.
20. Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 2011; 32; 241-247.
21. Farinha P, Masoudi H, Skinnider BF et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005; 106; 2169-2174.
22. Andjelic B, Mihaljevic B, Todorovic M, Bila J, Jakovic L, Jovanovic MP. The number of lymphoma-associated macrophages in tumor tissue is an independent prognostic factor in patients with follicular lymphoma. Appl. Immunohistochem. Mol. Morphol. 2012; 20; 41-46.
23. Steidl C, Lee T, Shah SP et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 2010; 362; 875-885.